HealthDay - System designed to work with magnetic resonance imaging devices
The first heart pacemaker designed to be used safely during certain MRI exams has been approved by the U.S. Food and Drug Administration.
Up to now, patients with pacemakers have been advised not to have an MRI, which has the potential to interfere with a pacemaker's settings and may cause the wiring to overheat, the FDA said in a news release.
The Revo MRI SureScan Pacing System has a built-in function that's meant to be turned on before a person undergoes an MRI. Even with the newly approved device, however, an MRI can only be used on certain people, on certain parts of the body, and under the supervision of specially trained technicians, the agency said.
Of 211 people implanted with the device who had an MRI during clinical testing, none had MRI-related complications, the FDA said.
The Revo device is produced by Medtronic Inc., based in Mounds View, Minn.
Copyright © 2011 HealthDay. All rights reserved.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.